Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
Samsung Bioepis Co., Ltd. today announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung Bioepis, including third-wave biosimilar candidates SB11 and SB12, which reference LUCENTIS® (ranibizumab) and SOLIRIS® (eculizumab), respectively, as well as SB3, a biosimilar candidate referencing HERCEPTIN® 3 (trastuzumab).
Under the agreement, C-Bridge will establish a new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis across a number of areas, including clinical development, regulatory registration and commercialization in China. Samsung Bioepis will receive an upfront payment, as well as royalties on sales. Additional financial details were not disclosed.
“We want to play an important role in widening access to high-quality healthcare for patients throughout China. C-Bridge is the right partner for this mission as evidenced in its exceptional track record of successfully turning portfolio companies like AffaMed Therapeutics into leading biopharmaceutical companies in China and beyond,” said Christopher Hansung Ko, President and Chief Executive Officer, Samsung Bioepis. “At Samsung Bioepis, we will continue to demonstrate our enduring commitment to biosimilars by further strengthening our pipeline and widening their availability for patients and healthcare systems across the world.”
Established in February 2012, Samsung Bioepis currently has four biosimilars approved and marketed across Europe, which include the anti-TNF trio of BENEPALI™ (etanercept), FLIXABI™ (infliximab) and IMRALDI™ (adalimumab), as well as an oncologic biosimilar, ONTRUZANT® (trastuzumab). In the United States, the company has one biosimilar – RENFLEXIS® (infliximab-abda) –.on the market, while another biosimilar – ONTRUZANT® (trastuzumab-dttb) – has been approved by the U.S. Food and Drug Administration (FDA). A Biologics License Application (BLA) for SB5 (adalimumab) biosimilar candidate is currently under review at the FDA.
In total, over 100,000 patients across the world are currently under treatment with Samsung Bioepis’ biosimilars, with over 6 million doses administered.
About AffaMed Therapeutics
AffaMed Therapeutics is a biopharmaceutical company focused on identifying and licensing late stage candidates for commercialization in emerging Asia Pacific markets and globally. AffaMed was founded and funded by C-Bridge Capital in 2019.
About C-Bridge Capital
C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities across healthcare industry. C-Bridge Capital’s current portfolio includes China’s leading players in pharmaceuticals, medical devices, diagnosis and healthcare services. As of today, the AUM of C-Bridge Capital has exceeded US$1.8 Billion. C-Bridge Capital is committed to support commercialization of cutting-edge technologies and companies that fulfil unmet medical needs, thus continuously improving the standard and quality of care for patients.
About Samsung Bioepis Co., Ltd.
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology and hematology. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.
1 LUCENTIS ® is a registered trademark of Genentech
2 SOLIRIS ® is a registered trademark of Alexion
3 HERCEPTIN ® is a registered trademark of Genentech
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HanseWerk Natur Chooses INNIO to Bring Highly Efficient and Highly Flexible CHP Plant Online22.11.2019 16:36:00 EET | Press release
In Germany, renewable energy already makes up more than 40% of electricity consumption. Against this dynamic energy policy backdrop, utility company HanseWerk Natur GmbH and gas engine manufacturer INNIO Jenbacher* have today announced that a further “green” natural-gas combined heat and power (CHP) plant has been commissioned at the existing district heating plant in Wahlstedt, Segeberg, in Schleswig-Holstein. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191122005268/en/ (left to right) Carlos Lange, Matthias Bonse, Dr. Gerta Gerdes-Stolzke and Horst Kornelius formally commission the new CHP plant in Wahlstedt, Segeberg, in Schleswig-Holstein. Copyright: HanseWerk Natur The start of operations at the new natural gas-powered CHP plant, which has an output of 4.5 megawatts (MW), sees the total electrical output of the Wahlstedt energy facility climb to up to 7 MW. Consequently, more than 10,000 households can be supplied wi
Rick and Morty Get Schwifty in Zynga’s Hit Game, Merge Dragons!22.11.2019 16:00:00 EET | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced an in-game license deal with Adult Swim to bring characters from the Emmy Award-winning TV series, Rick and Morty, to Gram Games’ Merge Dragons!. Rick and Morty appear in the puzzle adventure game in a special live event taking place on November 22nd, 2019. Get ready to squanch some dragons, broh! This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191122005036/en/ Rick and Morty Get Schwifty in Zynga’s Hit Game, Merge Dragons! (Graphic: Businses Wire) The collaboration brings Rick and Morty to Merge Dragons!’s special events that reward players for healing land and collecting points. In the game, Rick and Morty are playing Merge Dragons! and hack their way into the game to retrieve the Stone of Reckoning, a powerful item that opens portals to forbidden worlds. This causes the pair to crash-land in Dragonia, the world of Merge Dragons!, where
TIP Announces the Increase of Its RCF Facility and New Raise Term Debt22.11.2019 12:00:00 EET | Press release
On 21 November 2019, TIP, a portfolio company of I Squared Capital, announced that it had successfully: increased its existing Revolving Credit Facility (RCF) from €967 million to €1,150.5 million with no change in pricing or structure. raised €274.5 million in the private placement term debt markets for the first time. The term loan tenor is seven years. The RCF facility was initially established in 2014 for five years with three banks in the syndicate and a total amount of €300m. The facility was refinanced in December 2018 to €967 million maturing in December 2023. The funding round was substantially oversubscribed and will partially support the recently announced PEMA acquisition in Europe, other capital investments and future acquisitions to strengthen further the businesses leading market position. Bob Fast, CEO, explains: “The increase of our RCF and the introduction of new term loans provide liquidity to close our PEMA acquisition while providing flexibility to grow further bot
Paidy to Offer Instant Buy-Now Pay Later Payments for Amazon’s Consumers in Japan22.11.2019 08:11:00 EET | Press release
Paidy Inc. ("Paidy"), the instant buy-now pay later payment service, announced that Paidy is now available on Amazon.co.jp (referred to as “Amazon”) as a payment option for customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191121006078/en/ Instant buy-now pay later payment service, Paidy is now available on Amazon.co.jp as a payment option for customers. (Graphic: Business Wire) With the goal of removing barriers and embracing simplicity, Paidy is an instant post-pay credit service with a simple UI/UX where consumers can make payments using just their email address and mobile phone number. Paidy aims to make a meaningful contribution to offer superior customer convenience on Amazon. Paidy’s Founder and Executive Chairman, Russell Cummer said: “We are deeply honored to be working with Amazon to offer a new and unique consumer experience to Amazon customers. We see tremendous potential to work with Amazon and other par
Carbon Appoints Ellen Kullman President and CEO, Dr. Joseph DeSimone Named Executive Chairman21.11.2019 21:02:00 EET | Press release
Carbon (www.carbon3d.com), the world’s leading digital manufacturing platform, announced today that Ellen J. Kullman, former Chairman and CEO of DuPont, has been named President and CEO of the company and Dr. Joseph M. DeSimone has been named Executive Chairman of the Board, effective immediately. Kullman will also remain on Carbon’s board of directors where she has served since 2016. Today’s leadership announcements are the result of a succession plan that DeSimone, Kullman, and members of the board have worked on to prepare the company for its next chapter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191121005835/en/ Carbon Appoints Ellen Kullman President and CEO, Dr. Joseph DeSimone Named Executive Chairman (Photo: Business Wire) Carbon has been strengthening its leadership bench over the past several months to support the growth of the business. As President and CEO, Kullman will lead the development and execution of
New Spanish OTT Provider Plataforma Multimedia de Operadores Selects Verimatrix for Optimal Video Streaming Security21.11.2019 19:40:00 EET | Press release
Regulatory News: Verimatrix, (Paris:VMX), a global provider of security and business intelligence solutions that protect content, devices, applications and communications, today announced that Plataforma Multimedia de Operadores has joined a long list of customers that trust Verimatrix Multi-DRM. The Spanish OTT video provider selected the solution to provide a complete multi-screen security solution for its brand-new OTT service. Plataforma Multimedia de Operadores is a new company created by the main players of the historical cable industry in Spain offering a purely OTT-based TV platform delivered via Android set-top boxes, smartphones, tablets, laptops and smart TVs. Supported by Verimatrix partners Mirada and Anevia, the platform delivers content with a cutting-edge viewing experience and offers unique tools for content discovery, personal recommendations, session transfer, cloud DVR and much more. “We developed our platform to provide Spanish audiences with a flexible, reliable,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom